SCHEMBL30884643

SCHEMBL30884643

Cc1nn(C)cc1-c1nccc(N)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
COMT P21964 1/20 0.44
BRD4 O60885 1/20 0.38
HPGD P15428 1/20 0.36
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MTOR P42345 1/20 0.34
EGFR P00533 1/20 0.34
RPS6KA5 O75582 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
BRAF P15056 1/20 0.34
MAPK3 P27361 1/20 0.34
MAPK1 P28482 1/20 0.34
MAP3K7 O43318 1/20 0.33
TAB1 Q15750 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29195175 1.00 ALDH1A1 (0.46) ALDH1A1COMTBRD4HPGDKDM4E
SCHEMBL16340758 0.83 COMT (0.46) ALDH1A1COMTBRD4HPGDSMN1; SMN2
SCHEMBL25406827 0.83 ADORA2A (0.37) ALDH1A1KDM4ERPS6KA5IRAK4BRAF
SCHEMBL30606259 0.83 ADORA2A (0.37) ALDH1A1KDM4ERPS6KA5IRAK4BRAF
SCHEMBL30911867 0.75 MEN1 (0.34) ALDH1A1MEN1KMT2ASMN1; SMN2MTOR
SCHEMBL16320548 0.70 ALDH1A1 (0.49) ALDH1A1COMTBRD4HPGDKDM4E
SCHEMBL2190600 0.70 CYP2C9 (0.42) ALDH1A1KDM4EMEN1NOS3NOS1
SCHEMBL27754726 0.70 HSP90AA1 (0.42) KDM4EMEN1NOS3NOS1NOS2
SCHEMBL28335609 0.69 CYP1A2 (0.60) ALDH1A1NOS3NOS1NOS2SMN1; SMN2
SCHEMBL20936832 0.69 ALDH1A1 (0.44) ALDH1A1COMTBRD4NOS3NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117865939-A Aminopyrimidine derivative inhibitor, preparation method and application thereof 江苏豪森药业集团有限公司 2024-04-12 CN disclosed